|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 01/03/2011 |
| Corporate Officer/Principal | - | 01/03/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 01/03/2011 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.84% | +6.41% | +70.92% | +145.80% | 1,14800Cr | |
| +1.52% | +3.37% | +48.24% | +88.14% | 65TCr | |
| +1.74% | +2.35% | +29.65% | +105.72% | 51TCr | |
| +0.76% | +3.03% | +55.15% | +67.43% | 38TCr | |
| +4.87% | +0.94% | +71.66% | +44.74% | 35TCr | |
| +2.89% | +3.71% | +35.70% | +57.93% | 29TCr | |
| +2.38% | +1.29% | +4.68% | +28.67% | 26TCr | |
| +3.01% | +4.35% | +59.97% | +77.35% | 24TCr | |
| +2.06% | +3.75% | +37.62% | +109.70% | 20TCr | |
| Average | +3.13% | +1.39% | +45.95% | +80.61% | 44.86TCr | |
| Weighted average by Cap. | +3.98% | +1.50% | +51.47% | +95.35% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
